Andrew Parker
Chief Executive Officer at ArisGen SA
Profile
Andrew Parker is currently the Chief Executive Officer of ArisGen SA and the Chief Executive Officer & Member-Supervisory Board of Step Pharma SAS.
Previously, he worked as the General Partner & Scientific Director of Eclosion2 SA, Independent Director of GeNeuro SA (Switzerland), Scientific Director & General Partner of Eclosion2 & Cie Scpc, Principal at AstraZeneca PLC and Beerse Betonhandel, Vice President & Head-Exploratory Projects at Shire Plc, Chief Science Officer & Executive Vice President at Zealand Pharma A, Principal at Janssen Pharmaceutica NV, and Vice President-Pre Clinical Research at Opsona Therapeutics Ltd.
Dr. Parker holds an MBA from Warwick Business School and a doctorate from The National Institute For Medical Research.
Andrew Parker active positions
Companies | Position | Start |
---|---|---|
ArisGen SA
ArisGen SA Pharmaceuticals: MajorHealth Technology ArisGen SA manufactures novel products. The private company is based in Plan-les-Ouates, Switzerland. The CEO of the Swiss company is Andrew Parker. | Chief Executive Officer | - |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Chief Executive Officer | 2019-09-04 |
Former positions of Andrew Parker
Companies | Position | End |
---|---|---|
ZEALAND PHARMA A/S | Chief Tech/Sci/R&D Officer | 2019-08-30 |
Eclosion2 SA
Eclosion2 SA Financial ConglomeratesFinance Eclosion2 SA provides financial services. | Corporate Officer/Principal | - |
Eclosion2 & Cie Scpc | Corporate Officer/Principal | - |
SHIRE | Corporate Officer/Principal | - |
GENEURO SA | Director/Board Member | - |
Training of Andrew Parker
Warwick Business School | Masters Business Admin |
The National Institute For Medical Research | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
ASTRAZENECA PLC | Health Technology |
ZEALAND PHARMA A/S | Health Technology |
GENEURO SA | Health Technology |
Private companies | 8 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Beerse Betonhandel
Beerse Betonhandel Regional BanksFinance Part of Douterloigne Betonwerken, Beerse Betonhandel is a Belgian company that has a description related to depository banking functions not classified elsewhere. Beerse Betonhandel was acquired by Douterloigne Betonwerken on February 01, 1999. | Finance |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Health Technology |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Health Technology |
Eclosion2 SA
Eclosion2 SA Financial ConglomeratesFinance Eclosion2 SA provides financial services. | Finance |
Eclosion2 & Cie Scpc | |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Health Technology |
ArisGen SA
ArisGen SA Pharmaceuticals: MajorHealth Technology ArisGen SA manufactures novel products. The private company is based in Plan-les-Ouates, Switzerland. The CEO of the Swiss company is Andrew Parker. | Health Technology |
- Stock Market
- Insiders
- Andrew Parker